After a first demonstration phase in laboratory settings, the prototype is piloted by the NICUs- Neonatal Intensive Care Units - of two public hospitals that are partners in the project: Rigshospitalet of Copenhagen (24 doctors and 120 nurses treat about 1,000 newborns per year); Ospedale Maggiore Policlinico of Milan (22 medical doctors and 60 nurses assist about 600 newborns per year admitted to NICU and special care unit).

The role of the two hospitals is to test the device in different clinical situations:

  • the tool is evaluated under a sufficient range of realistic conditions and disease profiles to be able to assess its applicability fitting as far as possible in the clinical workflow, protocols and procedures, therefore the application in environmental neonatology
  • the end-users not only uses the tool, but also proactively drives its definition and the successive implementation from the prototype stage to the demonstrator level.

Furthermore, the BabyLux project addresses necessary regulatory, safety and standardization issues and provide appropriate ethical and privacy safeguards, with the ultimate goal of bridging the gap for the introduction into the market.



CIP

BabyLux is a project funded by the European Union under the Competitiveness and Innovation Framework Programme 2007-2013 (Grant agreement n. 620996)